CT-derived fractional flow reserve for prediction of major adverse cardiovascular events in diabetic patients. 2023

Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, #85 Wujin Rd, Shanghai, 200080, China.

To investigate the prognostic value of computed tomography fractional flow reserve (CT-FFR) in patients with diabetes and to establish a risk stratification model for major adverse cardiac event (MACE). Diabetic patients with intermediate pre-test probability of coronary artery disease were prospectively enrolled. All patients were referred for coronary computed tomography angiography and followed up for at least 2 years. In the training cohort comprising of 957 patients, two models were developed: model1 with the inclusion of clinical and conventional imaging parameters, model2 incorporating the above parameters + CT-FFR. An internal validation cohort comprising 411 patients and an independent external test cohort of 429 patients were used to validate the proposed models. 1797 patients (mean age: 61.0 ± 7.0 years, 1031 males) were finally included in the present study. MACE occurred in 7.18% (129/1797) of the current cohort during follow- up. Multivariate Cox regression analysis revealed that CT-FFR ≤ 0.80 (hazard ratio [HR] = 4.534, p < 0.001), HbA1c (HR = 1.142, p = 0.015) and low attenuation plaque (LAP) (HR = 3.973, p = 0.041) were the independent predictors for MACE. In the training cohort, the Log-likelihood test showed statistical significance between model1 and model2 (p < 0.001). The C-index of model2 was significantly larger than that of model1 (C-index = 0.82 [0.77-0.87] vs. 0.80 [0.75-0.85], p = 0.021). Similar findings were found in internal validation and external test cohorts. CT-FFR was a strong independent predictor for MACE in diabetic cohort. The model incorporating CT-FFR, LAP and HbA1c yielded excellent performance in predicting MACE.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072226 Computed Tomography Angiography A non-invasive method that uses a CT scanner for capturing images of blood vessels and tissues. A CONTRAST MATERIAL is injected, which helps produce detailed images that aid in diagnosing VASCULAR DISEASES. Angiography, CT,Angiography, Computed Tomography,CT Angiography,Angiographies, CT,Angiographies, Computed Tomography,CT Angiographies,Computed Tomography Angiographies,Tomography Angiographies, Computed,Tomography Angiography, Computed
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
August 2021, Cardiovascular diagnosis and therapy,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
January 2019, Journal of cardiovascular computed tomography,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
January 2002, Zeitschrift fur Kardiologie,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
April 2021, JAMA,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
October 2017, Radiology,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
June 2019, Radiology. Cardiothoracic imaging,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
April 2021, JAMA,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
November 2023, Zhonghua nei ke za zhi,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
September 2023, Clinical radiology,
Ziting Lan, and Xiaoying Ding, and Yarong Yu, and Lihua Yu, and Wenli Yang, and Xu Dai, and Runjianya Ling, and Yufan Wang, and Wenyi Yang, and Jiayin Zhang
April 2014, Journal of the American College of Cardiology,
Copied contents to your clipboard!